Human papillomavirus (HPV) is a small double-stranded DNA virus that commonly infects
humans. The oncogenic characteristics of HPV derive from the oncoproteins E6 and E7 that …

Cervical cancer is the third most common cancer in women worldwide, with concepts and
knowledge about its prevention and treatment evolving rapidly. Human papillomavirus …

Background Estimates of the lifetime probability of acquiring human papillomavirus (HPV)
can help to quantify HPV incidence, illustrate how common HPV infection is, and highlight …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

This chapter addresses the natural history of anogenital human papillomavirus (HPV)
infection. Cervical infections are the best understood HPV infection. Cervical HPV …

To provide updates for the 2015 Centers for Disease Control and Prevention sexually
transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital …

Human papillomavirus (HPV) vaccine uptake consistently lags behind that of other
adolescent vaccines. In 2017, uptake of a single HPV vaccine dose and HPV vaccine series …

Highlights•Latent papillomavirus infection can be mediated via at least two
routes.•Resolution of disease by the immune system results in basal cell persistence.•Low …

Disturbed vaginal microbiota have a role in the persistence of high-oncogenic-risk human
papillomavirus (hrHPV) and Gardnerella spp. is closely related with this condition. Such …

Background Assessment of the prevaccination type-specific prevalence of human
papillomavirus (HPV) in the general population is important for the prediction of the impact of …